Prescription drug · ANDA
Trihexyphenidyl Hydrochloride NDC 70954-212
Trihexyphenidyl hydrochloride 2 mg/1 · Tablet · Oral · Novitium Pharma LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70954-212-10 | 70954021210 | 100 TABLET in 1 BOTTLE (70954-212-10)Marketed from Jan 28, 2019 | |
| 70954-212-20 | 70954021220 | 1000 TABLET in 1 BOTTLE (70954-212-20)Marketed from Jan 28, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Trihexyphenidyl Hydrochloride
- Generic name (nonproprietary)
- trihexyphenidyl hydrochloride
- Active ingredients
- Trihexyphenidyl hydrochloride — 2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Novitium Pharma LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040254
- Marketing start
- Listing expires
- Identifiers
- Product ID 70954-212_83608c13-509d-448b-8559-5f5e8a9a0d75SPL ID 83608c13-509d-448b-8559-5f5e8a9a0d75SPL set ID 83608c13-509d-448b-8559-5f5e8a9a0d75RxCUI 905269, 905283UNII AO61G82577UPC 0370954212102, 0370954211105
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470954021210followed by a unit qualifier and the quantityPackage 70954-0212-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE This drug is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040254
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Trihexyphenidyl Hydrochloride | Trihexyphenidyl hydrochloride 5 mg/1 | TabletOral | Golden State Medical Supply Inc. | 51407-266 |
| Trihexyphenidyl Hydrochloride | Trihexyphenidyl hydrochloride 2 mg/1 | TabletOral | Golden State Medical Supply Inc. | 51407-265 |
| Trihexyphenidyl Hydrochloride | Trihexyphenidyl hydrochloride 5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2409 |
| Trihexyphenidyl Hydrochloride | Trihexyphenidyl hydrochloride 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2410 |
| Trihexyphenidyl Hydrochloride | Trihexyphenidyl hydrochloride 5 mg/1 | TabletOral | Novitium Pharma LLC | 70954-211 |